We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Otis is not obligated to purchase any shares under this authorization and may discontinue share repurchases at any time or periodically without notice. The timing, amount and form of future share ...

(RTTNews) - While reporting financial results for the fourth quarter on Wednesday, Otis Worldwide Corp. (OTIS) initiated adjusted earnings and net sales guidance for the full-year 2025, below ...

Otis Q4 sales beat estimates, but EPS missed expectations. 2025 sales and EPS outlook came in below consensus estimates. NOW OPEN: 200 Charter Memberships to Benzinga Trade Alerts Otis Worldwide ...

Otis Worldwide Corporation OTIS has reported mixed results in the fourth quarter of 2024, wherein adjusted earnings missed the Zacks Consensus Estimate while net sales topped the same. This is the ...

(Reuters) - Otis forecast 2025 profit below estimates and missed fourth-quarter profit expectations on Wednesday on sustained weakness in demand for new equipment in China, sending the shares of the ...

SINGAPORE – Certificate of entitlement (COE) prices fell for all categories except motorcycles on Feb 5, with the category for smaller cars seeing the sharpest drop of 9.2 per cent. The premium ...

SINGAPORE – Certificate of entitlement (COE) prices dropped across all categories on Jan 22, with the premium for motorcycles recording the biggest decrease of 14.2 per cent to $7,721.

Gabby Jones / Bloomberg / Getty Images Johnson & Johnson is scheduled to report fourth-quarter earnings Wednesday morning, with analysts expecting sales and profits to grow year-over-year.

SINGAPORE: The overall supply of Certificates of Entitlement (COE) for the February to April period will go up by 8 per cent compared with the previous quarter, the Land Transport Authority said ...

Johnson's Lions offense under head coach Dan Campbell was second in yards, first in first downs and first in scoring. They were sixth in rushing and second in passing. Along the way, Johnson ...

Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged him and caused infections. Johnson experienced ...